Greece Pharmaceuticals & Healthcare Report Q4 2015 - New Market Research Report

Despite the parlous state of the Greek economy and the imposition of emergency capital controls, drugmakers will maintain their commitment to the country's pharmaceutical market and ensure continuity of supply. Authorities will further restrict parallel exports to prevent medicine shortages. However, given that we expect Greece to return to a recession in 2015 and government revenues to fall, liquidity issues within the pharmaceutical supply chain will persist and debts within the Greek healthcare system will continue to accumulate.

Headline Expenditure Projections

Pharmaceuticals: EUR4.96bn (USD6.64bn) in 2014 to EUR4.85bn (USD5.34bn) in 2015 -2.1% in local currency terms and -19.6% in US dollar terms. Forecast unchanged from Q 3 15.
Healthcare: EUR16.17bn (USD21.66bn) in 2014 to EUR15.38bn (USD16.92bn) in 2015 -4.9% in local currency terms and -21.9 in US dollar terms. Forecast down from Q 3 15.

Full Report Details at
- http://www.fastmr.com/prod/1058392_greece_pharmaceuticals.aspx?afid=301

Risk/Reward Index

In BMI's Q415 Pharmaceutical Risk/Reward Index (RRIs) Greece falls to sixth place out of the 20 markets in the Central and Eastern European (CEE) matrix with a RRI score of 55 out of 100; down from fifth place with the same score of 55. Out of the 20 countries in our Index, Greece comes behind Poland and the Czech Republic and loses its Q315 rank to Slovakia. Greece has experienced a marked uptick in financial and political uncertainty as the new government faces mounting pressure to balance the increasingly urgent demands of both its international creditors in addition to the Greek electorate.

The Greece Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Greece Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Greece pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Greece, to test other views - a key input for successful budgeting and strategic business planning in the Greek pharmaceutical and healthcare market.
* Target business opportunities and risks in the Greek pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Greece.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Bahrain Pharmaceuticals & Healthcare Report Q4 2015
- Romania Pharmaceuticals & Healthcare Report Q4 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q4 2015
- Peru Pharmaceuticals & Healthcare Report Q4 2015
- Latvia Pharmaceuticals & Healthcare Report Q4 2015